- Investing Ideas
- U.K. Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
U.K. Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
2
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
2 companies
AstraZeneca
Market Cap: UK£195.9b
AstraZeneca PLC, empresa biofarmacéutica, centra su actividad en el descubrimiento, desarrollo, fabricación y comercialización de medicamentos de venta con receta.
AZN
UK£125.94
7D
-1.9%
1Y
22.3%
hVIVO
Market Cap: UK£47.1m
hVIVO plc opera como empresa de servicios farmacéuticos e investigación por contrato en el Reino Unido, Europa y Norteamérica.
HVO
UK£0.067
7D
-2.2%
1Y
-34.0%